$Aeglea BioTherapeutics, Inc.(AGLE)$ 8-K - Current report Filed: 2018-06-08 AccNo: 0001564590-18-015316 Size: 51 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接